Menu
/REGISTER
Montecito
Giving Guide
PacPremier
Loading...
You are here:  Home  >  'Roche'
Latest

Amgen adds two cancer treatment biosimilars to the market

By   /  Monday, July 22nd, 2019  /  Latest news  /  Comments Off on Amgen adds two cancer treatment biosimilars to the market

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Genentech sues Amgen over biosimilar drug info

By   /  Monday, February 20th, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Genentech sues Amgen over biosimilar drug info

Roch AG subsidiary Genentech filed a lawsuit against Amgen claiming the Thousand Oaks-based company obstructed its investigation of whether the biosimilar Amgen is developing for Genentech’s cancer treatment Avastin violates the company’s patents, according to reports Feb. 20. Sales for Avastin, a treatment for lung, colon, ovarian and other types of cancer, reached $6.8 billion Read More →

Read More →
Latest

Study shows Amgen’s new biosimilar cancer drug safe, effective

By   /  Wednesday, September 23rd, 2015  /  Latest news, Technology, Top Stories  /  Comments Off on Study shows Amgen’s new biosimilar cancer drug safe, effective

Pharmaceuticals Amgen and Allergan announced positive Phase 3 study results of their new drug ABP 215 on Sept. 23. The drug, used to treat lung cancer, is being developed as a biosimilar to Roche Holding AG’s Avastin. ABP 215 showed clinical safety and effectiveness compared to Avastin. “Lung cancer is the leading cause of cancer Read More →

Read More →